Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-256678
Filing Date
2018-08-24
Accepted
2018-08-24 06:08:22
Documents
14
Period of Report
2018-08-21

Document Format Files

Seq Description Document Type Size
1 6-K d620102d6k.htm 6-K 9465
2 EX-99.1 d620102dex991.htm EX-99.1 6728
3 EX-99.2 d620102dex992.htm EX-99.2 1331674
4 GRAPHIC g620102dsp35.jpg GRAPHIC 2762
5 GRAPHIC g620102dsp36.jpg GRAPHIC 11433
6 GRAPHIC g620102dsp381.jpg GRAPHIC 3032
7 GRAPHIC g620102dsp38b.jpg GRAPHIC 3064
8 GRAPHIC g620102g0821181046351.jpg GRAPHIC 2043
9 GRAPHIC g620102g0821181046476.jpg GRAPHIC 3304
10 GRAPHIC g620102g0821181046585.jpg GRAPHIC 2016
11 GRAPHIC g620102g0821181046710.jpg GRAPHIC 2023
12 GRAPHIC g620102g66d99.jpg GRAPHIC 2577
13 GRAPHIC g620102g84l55.jpg GRAPHIC 2478
14 GRAPHIC g620102g90d70.jpg GRAPHIC 2190
  Complete submission text file 0001193125-18-256678.txt   1401470
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 181035803
SIC: 2834 Pharmaceutical Preparations